Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.

Marco PuthenparampilMarta GaggiolaAlessandro MisciosciaValentina Annamaria MauceriFederica De NapoliGiovanni ZanotelliMariagiulia AnglaniMargherita NosadiniStefano SartoriPaola PeriniFrancesca RinaldiPaolo Gallo

Published in: Therapeutic advances in neurological disorders (2023)

ALZ seems more effective in AOMS than in POMS following NTZ. These findings underrate ALZ effectiveness when shifting from NTZ in POMS.

Keyphrases

multiple sclerosis
white matter
intensive care unit
emergency department
systematic review